Intravenous Injection of Hydrogen Nanobubble as complementary therapy for degenerative disease
-
Research duration : 2022-2025
-
Funding : Reverse Aging and homeostasis (RAHO) club
-
Research partners : Faculty of Computer Science, Universitas Brawijaya Hospital, SATORIA
Background
The advancements in medical technology and health sciences have led to various innovations in therapy and treatment. One area currently receiving attention is complementary therapy, which involves the use of alternative or additional methods alongside conventional treatments. Among the various types of complementary therapies being researched and utilized, nanomedicine is gaining prominence.
Nanomedicine involves the application of nano-scale technology in the field of medicine. Nano-sized materials typically range between 1 and 100 nanometers. This small size allows nano materials to penetrate cells and body tissues that are usually difficult to reach with conventional drugs. The large surface area relative to its volume also enables nano materials to carry more active substances and interact more effectively with biological targets. This technology is used in various applications in diagnosis, treatment, and disease prevention. Some advantages of nanomedicine include precise targeting, efficiency, and minimal side effects.
Hydrogen, the most abundant element in the universe, is relatively safe for use in medical therapy. Hydrogen possesses strong antioxidant capabilities. Hydrogen molecules can penetrate cells and mitochondria, providing protection against oxidative damage caused by free radicals such as superoxide anions (O₂⁻) and hydroxyl radicals (OH). These free radicals often lead to cell and tissue damage through oxidation, a process known as oxidative stress. Oxidative stress is closely associated with various health conditions, including cardiovascular diseases and neurodegenerative disorders like Parkinson disease.
Despite its potent therapeutic properties, hydrogen has low solubility and stability in water. Therefore, hydrogen bubble nanotechnology offers an innovative solution to address this issue. By enhancing stability, controlling diffusion, and ensuring efficient delivery, hydrogen bubble nanotechnology enables more effective and sustainable use of hydrogen in medical therapy. This makes it a promising approach in nanomedicine for treating various health conditions, particularly those related to cardiovascular health and parkinsonism.
Highlight of the research
The aim of this research project is to evaluate the effects of hydrogen bubble therapy on cardiovascular diseases and parkinsonism. The study focuses on understanding how this technology can provide therapeutic benefits for patients with cardiovascular disorders and those with Parkinson’s condition. By harnessing the antioxidant and anti-inflammatory potential of hydrogen, it is hoped that hydrogen bubble nanotechnology can offer a novel approach to treating both of these diseases.
The research is conducted comprehensively, starting from safety testing to clinical trials. Each stage of the study is designed to ensure that hydrogen bubble therapy is safe and effective before being applied to humans. Safety testing will involve animal models to assess potential side effects and toxicity, while clinical trials will involve patients to directly evaluate therapeutic effectiveness.
The data obtained during the research will be analyzed using AI technology. This approach allows for deeper and more accurate analysis, aiding in identifying patterns and therapy effectiveness. AI technology will be used to process the large datasets generated from clinical trials, providing a more comprehensive insight into how hydrogen bubble nanotechnology impacts patient health.
Overall, this research project aims to demonstrate significant benefits of hydrogen bubble therapy in managing cardiovascular diseases and Parkinsonism. With a systematic approach and the use of AI technology, this study has the potential to pave the way for more effective and safer medical therapies for patients.
Goals
1. Safety and Dosage of Intravenous Hydrogen Bubble Therapy:
-
To ensure safety, dosage, and effectiveness of intravenous hydrogen bubble therapy, research should include safety testing and clinical trials.
-
Safety testing involves using animal models to assess potential side effects and toxicity of intravenous hydrogen bubble injections. The dosage used should be determined based on pre-clinical studies and previous research
2. Effectiveness on Serum Lipids in Blood – Pre-Clinical Trial:
-
Pre-clinical trials aim to understand how intravenous hydrogen bubble injections affect blood lipid levels.
-
Data from pre-clinical trials will help determine the optimal dosage and understand the potential therapeutic effects on serum lipids.
3. Effectiveness on Cardiovascular Diseases – Clinical Trial:
-
Clinical trials will involve patients with cardiovascular diseases to evaluate the effectiveness of intravenous hydrogen bubble therapy.
-
These trials will provide direct insights into the therapeutic impact on cardiovascular health.
4. Effectiveness on Parkinsonism – Clinical Trial:
-
Clinical trials will also assess the effectiveness of intravenous hydrogen bubble therapy in treating Parkinsonism.
-
By involving patients, researchers can evaluate its impact on Parkinson’s symptoms.
Expected results
The expected outcomes of this research include confirming the safety and effectiveness of hydrogen bubble therapy, as well as developing treatment protocols that can be implemented in clinical practice. If successful, this research could pave the way for innovative and effective new therapies to manage cardiovascular diseases and parkinsonism, with the potential to significantly improve patients’ quality of life.
In addition to conventional analysis, all data collected from the preclinical stage to clinical trials will be used to develop an artificial intelligence (AI) model capable of predicting therapeutic responses in patients. This model is designed to identify subtle patterns in clinical parameters, such as changes in blood pressure, biomarkers, motor function in parkinsonism, and variability in individual responses to hydrogen nanobubble therapy. By utilizing machine learning and explainable AI techniques, researchers hope to build a prediction system that is not only accurate, but also capable of explaining the key factors that influence the success of therapy. This approach enables the development of more personalized and adaptive therapy protocols, so that each patient can obtain optimal benefits based on their individual clinical characteristics.
Download